Emerging trends in pharmaceutical design and drug manufacturing are shifting toward presenting the market with new ways to develop medications. Specialty medications continue to be a major area of pharmaceutical development and have become widely discussed in workers’ comp due to their significant costs. Although they represent approximately 1% of drug utilization, they account for nearly 7% of prescription drug costs and represent the fastest-growing segment of the U.S. pharmaceutical market. While specialty drug products are often associated with a hefty price tag, some can offer clinical advantages when deployed for the right patient at the right time, making careful oversight and patient selection imperative to achieving desired outcomes in this space. Watch the video blog to learn more.
More stories
Auto Casualty
News Release
Mitchell’s Plan to Address Michigan SB1 No-Fault Legislation for Bill Review
Michigan passed SB1 on May 30, 2019, which overhauls the Michigan auto no-fault system with a new fee schedule effective July 2021.
Enlyte
Blog
Virtual Connections: Utilizing Technology to Build and Deepen Relationships with Injured Workers
As the telemedicine industry continues to boom we’re seeing more and more new forms of telehealth emerge in the marketplace.
Mitchell
News Release
FDA Approves Generic Lyrica Pregabalin
Lyrica (pregabalin) is one of the most commonly prescribed drugs for neuropathic pain.
Mitchell
News Release
Mitchell Announces Partnership with Drew Technologies to Deliver OEM Scanning and Remote Diagnostic Support
SAN DIEGO, CA—Mitchell, a leading provider of technology, connectivity and information solutions to the
Workers' Comp
Article
StateWatch: Bill Review July 2019
Keep current with new legislation and its potential effect on your organization.
Workers' Comp
Blog
Understanding Brand & Generic Utilization and Cost
In 2018, First Script realized a 0.6% increase in generic utilization.